Las Vegas, NV -- (SBWIRE) -- 03/12/2013 -- MultiCell Technologies, Inc. (PINK:MCET) has recently issued its financial statements for the year 2012. Annual as well as quarterly reports for November 2012 are released. Quarterly and annual income statements show that the company is operating in loss.
MultiCell Technologies Inc reported the net loss of $1,256,000 last year and a net loss of $312,000 in quarter ending November 29, 2012. The major expense of the company is selling general and administrative expense that came out as $1,196,000 in annual report 2012 and $394,000 in November ending quarter.
MultiCell Technologies Inc is a biopharmaceutical company that develops therapeutics and discovers tools for the purpose of addressing treatment of neurological disorders, hepatic disease, cancer and interventional cardiology. The company pursues research and development to deal with degenerative neurological diseases like cancer and multiple sclerosis.
To find out what OTCMAGIC projects for MultiCell Technologies, Inc for both short term and long term please click here: MCET
OTCMAGIC Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly OTCMAGIC is the hottest thing in stock picks
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)